From MarketBeat:

Cresco Labs Inc saw a large drop in short interest in December, totaling 1,594,400 shares, a decrease of 8.1% from November. The days-to-cover ratio is 1.0 days based on the average daily volume of 1,552,500 shares. Shares in CRLBF stock traded at $1.36 on Tuesday, reaching a one year low of $1.00 and a one year high of $2.77. Cresco Labs reported ($0.04) EPS, with a negative return on equity of 11.72% and a negative net margin of 43.40%. The company’s revenue was $190.56 million during the quarter. ());

Analysts reaffirm an “outperform” rating on Cresco Labs stock. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating. The consensus target price of Cresco Labs stock is $6.58.

Cresco Labs Inc cultivates, manufactures, and sells retail and medical cannabis products in the United States. The company provides a variety of cannabis products under different brands, including Cresco, High Supply, Good News, Wonder Wellness Co, and Remedi. (MarketBeat)



Read more: Cresco Labs Inc. (OTCMKTS:CRLBF) Short Interest Down 8.1% in December